Codexis, Inc. (NASDAQ: CDXS), a developer of engineered enzymes for pharmaceutical, biofuel and chemical production, today announced the appointment of Greg Hughes, Ph.D., as Vice President, Strategic Alliance & Product Development, effective October 28, 2013. Dr. Hughes spent the last 11 years in Process Chemistry at Merck with a primary focus in developing and implementing biocatalysis technology.
Help employers find you! Check out all the jobs and post your resume.
